Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This article aimed to identify ...

Endospan today announced the presentation of 30-day results of the statistical Dissection Primary Arm from the TRIOMPHE Investigational Device Exemption (IDE) clinical study evaluating the NEXUS® ...

Mangaluru: The doctors at KMC Hospital saved the life of a 65-year-man who was battling a critically rare and fatal abdominal ...

The Driver and Vehicle Licensing Agency has revealed the complete list of health conditions that drivers need to declare - ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

KMC Hospital, saved the life of Shetty (name changed) who was battling with critically rare and fatal abdominal aortic ...

Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...